FIELD: medicine. SUBSTANCE: method involves carrying out selective catheterization of blood vessels feeding the lumps and introducing synthetic embolizing material into them. Intermediate stage and final embolization control is carried out within the operation by applying optical spectroscopy examination in 200-1500 nm bandwidth. The operation is finished when achieving cerebral oximetry values actual in pre-embolization period. EFFECT: avoided radiopaque substances administration; excluded risk of complications caused by their toxic action. 2 dwg
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR STOPPING HEMORRHAGE | 0 |
|
SU1097318A1 |
METHOD TO TREAT HEMANGIOMAS | 1996 |
|
RU2102014C1 |
METHOD OF TREATING ANGIODYSPLASIAS | 2013 |
|
RU2535105C2 |
METHOD FOR CHOOSING THE TACTICS OF MANAGEMENT OF PATIENTS WITH LIVER HEMANGIOMAS AT THE STAGE OF SURGICAL TREATMENT WITH INDICATIONS FOR EMBOLIZATION OF THE FETAL VESSEL | 2020 |
|
RU2751558C1 |
METHOD FOR CONTROLLING ANALGESIA AT PAIN FACTOR ACTION | 2004 |
|
RU2279249C2 |
COMPOSITION FOR EMBOLIZATION OF BLOOD VESSELS | 1995 |
|
RU2073529C1 |
METHOD OF TREATING DIFFUSE TOXIC GOITER | 1992 |
|
RU2028103C1 |
AGENT FOR REMOVING POST-NARCOSIS DEPRESSION | 2003 |
|
RU2254124C1 |
METHOD FOR ENDOVASCULAR TREATMENT OF CHRONIC HEMORRHOIDS BY LIQUID EMBOLIC MATERIAL | 2015 |
|
RU2624152C2 |
METHOD OF CATHETERIZATION AND METHOD OF ENDOVASCULAR OCCLUSION OF BRONCHIAL AND INTERCOSTAL ARTERIES | 2018 |
|
RU2661097C1 |
Authors
Dates
2004-05-27—Published
2002-06-21—Filed